The antiproliferative effect of the naturally occurring polyphenol chlorogenic acid (CGA) was evaluated in combination with either cisplatin or oxaliplatin in human cervical carcinoma cell lines that were either sensitive (A431) or resistant to cisplatin (A431Pt), in order to provide evidence to overcome drug resistance. Cytotoxicity of platinating drugs (IC50 ~ 10−6 - 10−5 M) was enhanced by 1–2 orders of magnitude by increasing incubation times (1, 4, and 24 hours) in the two cell lines. CGA treatment presented low cytotoxicity per se (IC50 ~ 10−4 M at 24 h) if compared with platinum drugs and its activity was similar in A431Pt cells and in their sensitive A431 counterpart. The combination of the platinating drugs with CGA (10−6 - 10−4 M) indicated variable effects on cytotoxicity, ranging from potentiation to various degrees of antagonism (in A431 cells) and no effect (in A431Pt cells). In order to explain the different cytotoxic activity elicited by oxaliplatin and cisplatin in association with CGA, the possible presence of chemical interactions was investigated by HPLC analysis. The drug association with CGA caused evident changes in their chromatographic profile, suggesting occurrence of in vitro chemical interactions.
KoberleB., TomicicM.T., UsanovaS., KainaB. (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochimica et Biophysica Acta, 1806, 172–182.
2.
GalluzziL., VitaleI., MichelsJ., BrennerC., SzabadkaiG., Harel-BellanA., CastedoM., KroemerG. (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death & Disease, 5, e1257.
3.
Martinez-BalibreaE., Martínez-CardúsA., GinésA., Ruiz de PorrasV., MoutinhoC., LayosL., ManzanoJ.L., BugésC., BystrupS., EstellerM., AbadA. (2015) Tumor-related molecular mechanisms of oxaliplatin resistance. Molecular Cancer Therapeutics, Published OnlineFirst July 16, 2015; doi: 10.1158/1535-7163.MCT-14-0636.
4.
AggarwalB.B., ShishodiaS. (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical Pharmacology, 71, 1397–1421.
5.
RodrigoR., LibuyM., FeliuF., HassonD. (2014) Polyphenols in disease: from diet to supplements. Current Pharmaceutical Biotechnology, 15, 304–317.
6.
FantiniM., BenvenutoM., MasuelliL., FrajeseG.V., TresoldiI., ModestiA., BeiR. (2015) In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. International Journal of Molecular Sciences, 16, 9236–9282.
7.
BonofiglioD., GiordanoC., De AmicisF., LanzinoM., AndoS. (2015) Natural products as promising antitumoral agents in breast cancer: Mechanisms of action and molecular targets. Mini Reviews in Medicinal Chemistry, 2015 Jul 9 [Epub ahead of print].
8.
ShayJ., ElbazH.A., LeeI., ZielskeS.P., MalekM.H., HüttemannM. (2015) Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxidative Medicine and Cell Longevity, 2015:181260. doi: 10.1155/2015/181260. [Epub 2015 Jun 9].
9.
CatanzaroD., VianelloC., RagazziE., CaparrottaL., MontopoliM. (2014) Cell cycle control by natural phenols in cisplatin-resistant cell lines. Natural Product Communications, 9, 1465–1468.
10.
CatanzaroD., RagazziE., VianelloC., CaparrottaL., MontopoliM. (2015) Effect of quercetin on cell cycle and cyclin expression in ovarian carcinoma and osteosarcoma cell lines. Natural Product Communications, 10, 1365–1368.
11.
WangL., GaoS., JiangW., LuoC., XuM., BohlinL., RosendahlM., HuangW. (2014) Antioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migration. International Journal of Molecular Sciences, 15, 16226–16245.
12.
JiangY., SatohK., AratsuC., KobayashiN., UntenS., KakutaH., KikuchiH., NishikawaH., OchiaiK., SakagamiH. (2001) Combination effect of lignin F and natural products. Anticancer Research, 21, 965–970.
13.
YanY.I., LiJ., HanJ., HouN., SongY., DongL. (2015) Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases. Anticancer Drugs, 26, 540–546.
14.
CliffordM.N. (1999) Chlorogenic acids and other cinnamates—nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture, 79, 362–372.
15.
KonoY., KobayashiK., TagawaS., AdachiK., UedaA., SawaY., ShibataH. (1997) Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochimica et Biophysica Acta—General Subjects, 1335, 335–342.
16.
KasaiH., FukadaS., YamaizumiZ., SugieS., MoriH. (2000) Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food and Chemical Toxicology, 38, 467–471.
17.
FengR., LuY., BowmanL.L., QianY., CastranovaV., DingM. (2005) Inhibition of activator protein-1, NF-κB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. Journal of Biological Chemistry, 280, 27888–27895.
18.
dos SantosM.D., AlmeidaM.C., LopesN.P., de SouzaG.E.P. (2006) Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biological and Pharmaceutical Bulletin, 29, 2236–2240.
19.
BassoliB.K., CassollaP., Borba-MuradG.R., ConstantinJ., Salgueiro-PagadigorriaC.L., BazotteR.B., da SilvaR.S., de SouzaH.M. (2008) Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochemistry and Function, 26, 320–328.
20.
MontopoliM., RagazziE., FroldiG., CaparrottaL. (2009) Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell Proliferation, 42, 195–206.
21.
KimT.Y., ParkJ., OhB., MinH.J., JeongT.S., LeeJ.H., SuhC., CheongJ.W., KimH.J., YoonS.S., ParkS.B., LeeDS; Korean Multiple Myeloma Working Party (KMMWP) (2009) Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction. British Journal of Haematology, 146, 270–281.
22.
BongiornoR.A., NutescuE.A. (2004) Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers. Seminars in Thrombosis and Hemostasis, 30, 619–626.
